IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,000 | -54.5% | 11,560 | -36.6% | 0.00% | – |
| Q1 2018 | $33,000 | -32.7% | 18,228 | -21.9% | 0.00% | – |
| Q4 2017 | $49,000 | +96.0% | 23,329 | +107.4% | 0.00% | – |
| Q3 2017 | $25,000 | +127.3% | 11,247 | +78.8% | 0.00% | – |
| Q2 2017 | $11,000 | -81.7% | 6,291 | -74.4% | 0.00% | – |
| Q1 2017 | $60,000 | +33.3% | 24,621 | -17.2% | 0.00% | – |
| Q4 2016 | $45,000 | -26.2% | 29,718 | +25.8% | 0.00% | – |
| Q3 2016 | $61,000 | +84.8% | 23,627 | +9.9% | 0.00% | – |
| Q2 2016 | $33,000 | -13.2% | 21,505 | +11.3% | 0.00% | – |
| Q1 2016 | $38,000 | -42.4% | 19,325 | -9.7% | 0.00% | – |
| Q4 2015 | $66,000 | +1.5% | 21,394 | +8.6% | 0.00% | – |
| Q3 2015 | $65,000 | -88.9% | 19,694 | -87.5% | 0.00% | – |
| Q2 2015 | $584,000 | +711.1% | 157,505 | +705.7% | 0.00% | – |
| Q1 2015 | $72,000 | -15.3% | 19,550 | +1.2% | 0.00% | – |
| Q4 2014 | $85,000 | +174.2% | 19,325 | +42.4% | 0.00% | – |
| Q3 2014 | $31,000 | -36.7% | 13,575 | -20.0% | 0.00% | – |
| Q2 2014 | $49,000 | -15.5% | 16,975 | +19.0% | 0.00% | – |
| Q1 2014 | $58,000 | -97.4% | 14,262 | -97.0% | 0.00% | -100.0% |
| Q4 2013 | $2,224,000 | +171.6% | 480,434 | +2.0% | 0.00% | – |
| Q3 2013 | $819,000 | +165.9% | 470,820 | +0.0% | 0.00% | – |
| Q2 2013 | $308,000 | – | 470,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|